Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
REVENUES        
Government contract revenue $ 17,117 $ 624,871 $ 281,049 $ 624,871
OPERATING EXPENSES        
Professional fees 433,404 624,979 1,666,333 1,845,659
Payroll and related expenses 999,500 1,523,650 2,821,850 2,520,805
General and administrative 1,112,159 920,632 2,428,053 1,885,332
Total operating expenses 2,545,063 3,069,261 6,916,236 6,251,796
OPERATING LOSS (2,527,946) (2,444,390) (6,635,187) (5,626,925)
NET LOSS (2,527,946) (2,444,390) (6,635,187) (5,626,925)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (2,214) (1,498) (4,174) (3,186)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,525,732) $ (2,442,892) $ (6,631,013) $ (5,623,739)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.16) $ (0.20) $ (0.46) $ (0.50)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED 15,397,418 12,093,361 14,543,787 11,265,725